Esketamine infusion during percutaneous balloon compression (PBC) of trigeminal ganglion for the amelioration of hypoesthesia: a pragmatic randomized controlled trial

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000039014

Enrollment

Unknown

Registered

2020-10-13

Start date

2020-10-01

Completion date

Unknown

Last updated

2021-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trigeminal Neuralgia

Interventions

control group :N/A

intervention group :Esketmine

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Primary or secondary trigeminal neuralgia patients who are at the age of 18 to 100 years.

Exclusion criteria

Exclusion criteria: 1.Contraindicated to PBC operation. 2.Contraindicated to drugs. 3.Combination of serious system conditions. 4.Refuse to cooperate with doctors. 5.Other conditions.

Design outcomes

Primary

Measure	Time frame
BNI-N Scale;	—

Secondary

Measure	Time frame
NRS;BNI Pain Scale;	—

Countries

China

Contacts

Public ContactJiang Zongbin

The Second Affiliated Hospital of Guangxi Medical University

2010pm@163.com+86 13978611623

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026